Lucia Cavelier

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal: Journal of internal medicine
Published: July 07, 2026

Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report.

Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report.

Journal: Frontiers in oncology
Published: April 14, 2025

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2024

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia.

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia.

Journal: Blood neoplasia
Published: October 21, 2024

Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing.

Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing.

Journal: Journal of medical economics
Published: August 05, 2024

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.

Journal: Genes, chromosomes & cancer
Published: May 07, 2024

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 17, 2024

Current and emerging sequencing-based tools for precision cancer medicine.

Current and emerging sequencing-based tools for precision cancer medicine.

Journal: Molecular aspects of medicine
Published: November 14, 2023

Novel precision medicine approaches and treatment strategies in hematological malignancies.

Novel precision medicine approaches and treatment strategies in hematological malignancies.

Journal: Journal of internal medicine
Published: July 10, 2023

Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA).

Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA).

Journal: Journal of internal medicine
Published: June 08, 2023

Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia.

Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia.

Journal: Frontiers in oncology
Published: May 05, 2023

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2023
Showing 1-12 of 51

Last Updated: 09/26/2026